MedTrace Logo

Endovascular Exclusion of TAAA/AAA Utilizing Fenestrated/Branched Stent Grafts

NCT00583050 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 1366

Last updated 2020-05-08

Study results available
· View outcomes & findings →

Summary

The purpose of the study is to evaluate the role of fenestrated/branched stent-grafts in the exclusion of abdominal aortic and thoracoabdominal aneurysms.

Conditions

  • Thoracoabdominal Aneurysm
  • Abdominal Aortic Aneurysm

Interventions

DEVICE

Endovascular Aneurysm Repair

Endovascular exclusion of aneurysm

Sponsors & Collaborators

  • Massachusetts General Hospital

    collaborator OTHER

  • The Cleveland Clinic

    lead OTHER

Principal Investigators

  • Behzad Farivar, M. D. · The Cleveland Clinic

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2001-02-28
Primary Completion
2019-12-31
Completion
2020-02-01

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00583050 on ClinicalTrials.gov